Report Highlights
INTRODUCTION
Miniaturization not only saves on scarce resources, such as purified proteins, but also decreases the time, another precious commodity, involved in doing assays.
Nanotechnology involves the miniaturization of devices beyond microengineering; however, at nanoscale, materials can have quite different properties, as different physical principles, for instance, van der Wall's forces, become more dominant. Intuitive understanding of forces like friction or surface tension are not useful at the nano level. Nanostructured materials may be very much stronger and lighter than conventional bulk materials. Some nanostructured materials have new and unexpected properties, such as "quantum dots" that fluoresce at different wavelengths depending upon their size. Nanomaterials may be used to create nanodevices with defined functions.
Biomolecules such as protein and DNA are also easily exploited to make nanodevices. Like fullerenes, biomolecules generally have a carbon backbone, but one that is widely substituted with modifiable chemical groups. Because their biochemistry is well understood, DNA and proteins are being used structurally now to build nanodevices.
The favorite manufactured items used by nanotechnologists have diameters comparable to smallest objects found in nature. Six-carbon atoms lined end to end are about 1 nm in diameter. Perhaps surprisingly, the synthetic molecule, buckminster fullerene, which contains 60 carbons, has the same diameter. Despite the large molecular weight, because C60 is approximately spherical is minimal. Even so, C60 can be made to cage other molecules, including some used for medical imaging purposes. Fullerene derivatives, such as nanotubes, have smaller diameters than C60. Commercially available nanoparticles are actually quite a bit smaller than cells, about the same size as an average virus.
It is apparent that nanoscale fabrication has already reached the scale of biomolecules. The problem that remains is how to apply nanotechnology to biomedical requirements, and even more difficult, how to make it marketable. Nanoscale devices are now being used for contrast agents for imaging purposes, for bioassays, as drug delivery agents, and even as drug equivalents.
Related Reports
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Emerging Drugs: Global Markets
The report provides an overview of the global emerging drugs and analyzes market trends, segmented by molecule type, product type, therapeutic application, and end user. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.
Lung Cancer Therapeutics: Global Markets
The global market for lung cancer therapeutics is expected to grow from $32.5 billion in 2025 and is projected to reach $49.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.8% during the forecast period of 2025 to 2030.
Global Bispecific Antibodies Market
This report provides an overview of the global bispecific antibodies market and analyzes market trends. It includes global revenue ($ million) for the base year data for 2022- 2024 and estimated data for the forecast period from 2025 through 2030.
Neuroprotective Agents: Therapeutic Applications and Global Markets
The global market for neuroprotective agents is expected to grow from $43.9 billion in 2025 and is projected to reach $60.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.7% during the forecast period of 2025 to 2030.
Radioligand Therapeutics in Cancer Treatment: Global Markets
The global market for radioligand therapeutics in cancer treatment is estimated to grow from $2.6 billion in 2025 to $4.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 through 2030.
Top Trending Reports
Stem Cell and Regenerative Therapy: Global Markets
The global market for stem cell and regenerative therapy is projected to grow from an estimated $16.7 billion in 2025 to $43.8 billion by 2030, at a compound annual growth rate (CAGR) of 21.3% from 2025 to 2030.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps and devices is expected to grow from $9.7 billion in 2025 and is projected to reach $14.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2025 to 2030.
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Noninvasive Cancer Diagnostics: Technologies and Global Markets
The global market for noninvasive cancer diagnostic technologies is expected to grow from $119.9 billion in 2025 and is projected to reach $165.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.6% during the forecast period of 2025 to 2030.
Neuroprotective Agents: Therapeutic Applications and Global Markets
The global market for neuroprotective agents is expected to grow from $43.9 billion in 2025 and is projected to reach $60.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.7% during the forecast period of 2025 to 2030.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More